Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial.
Voltin CA, Mettler J, van Heek L, Goergen H, Müller H, Baues C, Keller U, Meissner J, Trautmann-Grill K, Kerkhoff A, Fuchs M, Sasse S, von Tresckow B, Dietlein M, Borchmann P, Engert A, Kobe C, Bröckelmann PJ.
Voltin CA, et al.
Clin Cancer Res. 2021 Jan 15;27(2):402-407. doi: 10.1158/1078-0432.CCR-20-3303. Epub 2020 Oct 29.
Clin Cancer Res. 2021.
PMID: 33122344
Clinical Trial.